Direktorat Registrasi ObatValid

OFLOXACIN

BPOM Number: GKL0433510217A1
Approved: 22 July 2025
Expiry: 10 September 2029
Form: TABLET SALUT SELAPUT

About This Registration

OFLOXACIN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL0433510217A1. Its current registration status is Valid, with the licence valid until 10 September 2029. The product is registered to NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA. BPOM first approved this registration in July 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 5 STRIP @ 10 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
KAB. BOGOR
NPWP: 010026805052000
owner
View profile →

Manufacturing Sites

NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA
KAB. BOGOR
primary
View profile →

Ingredients (1)

OFLOXACIN

Market Intelligence

Owner Portfolio: NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA holds 567 BPOM registrations
Manufacturer Scale: NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA produces 567 registered products
Registration Age: Registered for 1 year, 2 months

FDA Cross-Reference

via openFDA

Generic Name: OFLOXACIN OTIC
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: AURICULAR (OTIC)

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?